tiprankstipranks
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market

Denali Therapeutics (DNLI) Financial Statements

Compare
672 Followers

Denali Therapeutics Financial Overview

Denali Therapeutics's market cap is currently $1.97B. The company's EPS TTM is $-2.575; its P/E ratio is ―; Denali Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 330.53M$ 108.46M$ 48.66M$ 335.66M
Gross Profit$ 0.00$ 313.81M$ 101.43M$ 43.05M$ 123.04M
Operating Income$ -487.34M$ -196.70M$ -340.74M$ -295.75M$ 62.72M
EBITDA$ -487.34M$ -179.97M$ -330.36M$ -287.16M$ 62.72M
Net Income$ -422.77M$ -145.22M$ -325.99M$ -290.58M$ 71.14M
Balance Sheet
Cash & Short-Term Investments$ 832.33M$ 1.03B$ 1.34B$ 865.41M$ 1.47B
Total Assets$ 1.37B$ 1.15B$ 1.46B$ 1.40B$ 1.60B
Total Debt$ 42.29M$ 52.24M$ 60.35M$ 58.55M$ 64.17M
Net Debt$ -132.67M$ -74.86M$ -157.69M$ -234.92M$ -442.97M
Total Liabilities$ 144.50M$ 122.96M$ 417.81M$ 441.87M$ 453.75M
Stockholders' Equity$ 1.23B$ 1.03B$ 1.04B$ 962.29M$ 1.15B
Cash Flow
Free Cash Flow$ -363.61M$ -370.93M$ -262.55M$ -219.89M$ 413.06M
Operating Cash Flow$ -347.69M$ -357.99M$ -244.72M$ -211.39M$ 416.15M
Investing Cash Flow$ -88.76M$ 249.31M$ -141.39M$ -21.63M$ -623.21M
Financing Cash Flow$ 484.30M$ 17.82M$ 310.67M$ 19.35M$ 634.75M
Currency in USD

Denali Therapeutics Earnings and Revenue History

Denali Therapeutics Debt to Assets

Denali Therapeutics Cash Flow

Denali Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis